We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.8%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.4B
AUM Growth
+$1.11B
(+5.8%)
Cap. Flow
+$100M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
18.19%
Holding
3,316
New
217
Increased
1,367
Reduced
1,468
Closed
167
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$43.9M |
| 2 |
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
|
+$31.7M |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$27.7M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$26.5M |
| 5 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$44.6M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$30.3M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$30.3M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$30.2M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$28.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.45% |
| 2 | Financials | 4.68% |
| 3 | Healthcare | 4.07% |
| 4 | Consumer Discretionary | 3.92% |
| 5 | Industrials | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
URG
2626
Ur-Energy
URG
$533M
| $254K | ﹤0.01% |
+239,463
| New | +$271K |
|
2627
Nice
NICE
$6.17B
| $253K | ﹤0.01% |
1,104
-183
| -14% | -$38.4K |
|
2628
Nuveen ESG Mid-Cap Value ETF
NUMV
$461M
| $253K | ﹤0.01% |
8,811
+83
| +1% | +$2.52K |
|
2629
ArcBest
ARCB
$3.28B
| $252K | ﹤0.01% |
+2,722
| New | +$245K |
|
|
EXK
2630
Endeavour Silver
EXK
$3.05B
| $252K | ﹤0.01% |
65,042
+46,066
| +243% | +$153K |
|
2631
Primis Financial Corp
FRST
$413M
| $252K | ﹤0.01% |
26,173
+13,354
| +104% | +$151K |
|
2632
HUB Group
HUBG
$2.55B
| $252K | ﹤0.01% |
6,000
-3,142
| -34% | -$137K |
|
2633
Impinj
PI
$5.46B
| $252K | ﹤0.01% |
1,860
-500
| -21% | -$63.7K |
|
2634
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $252K | ﹤0.01% |
13,734
-884
| -6% | -$16.3K |
|
2635
Innovator US Equity Buffer ETF June
BJUN
$323M
| $251K | ﹤0.01% |
7,850
-93
| -1% | -$2.93K |
|
2636
Alpha Architect Tail Risk ETF
CAOS
$694M
| $251K | ﹤0.01% |
+3,242
| New | +$246K |
|
2637
Genesco
GCO
$394M
| $251K | ﹤0.01% |
+6,808
| New | +$298K |
|
|
HIO
2638
Western Asset High Income Opportunity Fund
HIO
$338M
| $251K | ﹤0.01% |
65,863
-11,086
| -14% | -$44.1K |
|
2639
Independent Bank
INDB
$4.05B
| $251K | ﹤0.01% |
3,821
+3
| +0.1% | +$229 |
|
2640
iQIYI
IQ
$1.31B
| $251K | ﹤0.01% |
34,462
-4
| -0% | -$27 |
|
|
SKX
2641
DELISTED
Skechers
SKX
| $251K | ﹤0.01% |
5,280
+399
| +8% | +$18.1K |
|
2642
Medifast
MED
$128M
| $250K | ﹤0.01% |
+2,410
| New | +$267K |
|
|
DX
2643
Dynex Capital
DX
$3.23B
| $248K | ﹤0.01% |
20,480
+221
| +1% | +$2.95K |
|
|
NCV
2644
Virtus Convertible & Income Fund
NCV
$390M
| $247K | ﹤0.01% |
18,368
+700
| +4% | +$10.2K |
|
2645
RUM Group Inc
RUM
$3.74B
| $247K | ﹤0.01% |
24,697
+8,169
| +49% | +$73.6K |
|
|
MTTR
2646
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $247K | ﹤0.01% |
90,323
+1,022
| +1% | +$3.12K |
|
2647
Fluor
FLR
$7B
| $246K | ﹤0.01% |
7,956
-194
| -2% | -$6.67K |
|
2648
iShares MSCI USA Size Factor ETF
SIZE
$449M
| $246K | ﹤0.01% |
2,086
-198
| -9% | -$23.5K |
|
2649
Dorchester Minerals
DMLP
$1.35B
| $245K | ﹤0.01% |
8,098
-7,931
| -49% | -$235K |
|
2650
iShares Latin America 40 ETF
ILF
$3.69B
| $245K | ﹤0.01% |
+10,259
| New | +$246K |
|
Similar funds
LP
HF
Cambridge Investment Research Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Cambridge Investment Research Advisors held 3,316 positions worth $20.4B, up 5.8% from $19.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q1 2023 filing shows 217 new, 1,367 increased, 1,468 reduced and 167 closed positions. Its largest new stake was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $44.6M.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.
- Cambridge Investment Research Advisors's largest Q1 2023 buy was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M.
- Cambridge Investment Research Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $43.9M increase.
- Cambridge Investment Research Advisors's biggest Q1 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $44.6M.
- Cambridge Investment Research Advisors fully exited ProShares Short Russell2000 in Q1 2023, selling an estimated $4.61M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $20.4B portfolio in Q1 2023.
- Cambridge Investment Research Advisors opened 217 new positions and closed 167 in Q1 2023.
- Cambridge Investment Research Advisors's portfolio value rose 5.8% quarter-over-quarter to $20.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2023, filed 11 May 2023.